In this article, Paul Wilmshurst provides an overview of the main developments in the UK tax avoidance debate and how the UK transfer pricing environment may change as a result of these developments.
Drug pricing rules and tariffs reshape transfer pricing for IP
In the article “Drug Pricing Rules and Tariffs Reshape Transfer Pricing for IP,” published in Bloomberg Tax, CRA’s Transfer Pricing experts Robin Hart and ...